MPAM
AMED

Monarch Partners Asset Management’s Amedisys AMED Stock Holding History

Monarch Partners Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100,260
Closed -$6.3M – 181
2017
Q2 		$6.3M Sell
100,260
-75,590
-43% -$4.4M 0.62% 72
2017
Q1 		$8.98M Buy
+175,850
New +$8.39M 0.9% 42

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Monarch Partners Asset Management's AMED Position: Q3 2017 in Review

Monarch Partners Asset Management sold out of Amedisys (AMED) in Q3 2017, closing a stake of 100,260 shares — an estimated $6.3M sold.

Monarch Partners Asset Management first reported a position in AMED in Q1 2017 and held it in 2 quarters. The position peaked at $8.98M in Q1 2017. 163 funds tracked by Wall St. Rank hold AMED as of Q3 2017.

  • Monarch Partners Asset Management reported no remaining Amedisys position as of Q3 2017 after selling out during the quarter.
  • Monarch Partners Asset Management sold 100,260 Amedisys shares in Q3 2017, an estimated $6.3M.
  • Monarch Partners Asset Management first reported a position in Amedisys in Q1 2017 and held it in 2 quarters.
  • Monarch Partners Asset Management's Amedisys position peaked at $8.98M in Q1 2017.
  • 163 funds tracked by Wall St. Rank held Amedisys as of Q3 2017.

Based on Monarch Partners Asset Management's 13F filing for Q3 2017, filed 1 Nov 2017.